Wockhardt announces its exit from the US generics market, shifting focus to its innovative antibiotic and biologicals ...

Antibiotic innovation, rising female UTI cases, and diagnostic advances are key drivers shaping the future of the UTI market. CA, UNITED STATES, July 15, 2025 /EINPresswire.com/ -- Urinary tract ...

Mumbai-based pharma major Wockhardt, which is gearing up to launch its promising antibiotic candidate Zaynich soon, on Friday ...

Children under 5 with RSV or flu face higher bacteremia risk if febrile, under 6 months, or need respiratory support, with ...

BiomEdit has raised an $18.4m Series B round and is gearing up to launch its first product, a designer probiotic to tackle ...

By exiting the US generics space, the company aims to redirect capital and executive focus toward two key growth areas: novel ...

Voting at 16: more than just a symbolic gesture? The American Revolutionary War through the eyes of a Swiss immigrant Read more: The American Revolutionary War through the eyes of a Swiss immigrant Is ...

Mumbai: Wockhardt has announced a significant strategic realignment of its U.S. business, marking an exit from the generic ...

In the ongoing battle against antibiotic-resistant bacteria, MSU researchers have made a discovery that could reshape how we ...

Rapidly identifying certain bacteria allows antibiotic treatments to be optimised. A team from the University of Zurich, ...

Streptococcus (S.) suis infections have been causing significant challenges on sow farms. A Dutch study project maps the ...